Generation Bio (GBIO) Cash & Equivalents (2021 - 2025)
Historic Cash & Equivalents for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $21.9 million.
- Generation Bio's Cash & Equivalents rose 130.67% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year increase of 130.67%. This contributed to the annual value of $76.3 million for FY2024, which is 1483.16% up from last year.
- Generation Bio's Cash & Equivalents amounted to $21.9 million in Q3 2025, which was up 130.67% from $49.1 million recorded in Q2 2025.
- Generation Bio's Cash & Equivalents' 5-year high stood at $392.1 million during Q2 2021, with a 5-year trough of $21.7 million in Q3 2024.
- In the last 5 years, Generation Bio's Cash & Equivalents had a median value of $93.4 million in 2023 and averaged $154.2 million.
- In the last 5 years, Generation Bio's Cash & Equivalents plummeted by 8034.14% in 2024 and then soared by 7226.57% in 2025.
- Over the past 5 years, Generation Bio's Cash & Equivalents (Quarter) stood at $375.1 million in 2021, then plummeted by 75.16% to $93.2 million in 2022, then decreased by 28.68% to $66.4 million in 2023, then grew by 14.83% to $76.3 million in 2024, then tumbled by 71.25% to $21.9 million in 2025.
- Its Cash & Equivalents was $21.9 million in Q3 2025, compared to $49.1 million in Q2 2025 and $50.9 million in Q1 2025.